Gene therapy of hepatocellular carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Biotechnology

Background:

• Hepatocellular carcinoma (liver cancer) remains a significant global health challenge with limited treatment options.
• Gene therapy presents a versatile approach for treating incurable diseases, including liver cancer.

Purpose of the Study:

• To review gene therapy strategies for hepatocellular carcinoma.
• To evaluate preclinical data and summarize clinical trials for liver cancer gene therapy.

Main Methods:

• Review of existing literature on gene therapy vectors.
• Analysis of preclinical studies in animal models of hepatocellular carcinoma.
• Summary of clinical trial outcomes for liver cancer gene therapy.

Main Results:

• Gene therapy employs diverse strategies like suicide gene therapy, immunogene therapy, and oncolytic viruses.
• While gene expression in tumors is achievable, current gene therapy vectors show poor performance.
• Clinical trial results for liver cancer gene therapy have been largely disappointing.

Conclusions:

• Despite challenges with current vectors, gene therapy holds promise for hepatocellular carcinoma treatment.
• Further advancements in gene therapy vector technology are crucial for improving clinical efficacy.
• Ongoing research and clinical trials are essential to realize the full potential of gene therapy for liver cancer.